Undervalued and underrated: Calix's case for a re-rate
31m 31s
The company has undergone a transformative journey from a pre-revenue green tech startup valued at $1 billion in 2021 at a share price of 53 cents, to a financially resilient business trading at 25 cents today. This decline reflects broader market shifts, including US political volatility, interest rate spikes, and the decline of clean tech momentum, which led to significant valuation discounts. However, a key strategic pivot in late 2023—focusing on the magnesium business—has delivered strong, sustainable cash flow, with EBITDA reaching $3.8 million in 2025. The US magnesium hydroxide market, with five to ten times larger customer size and long sales cycles, offers significant growth potential, supported by a growing pipeline of major industrial clients. The company also secured a pivotal partnership with Rio Tinto for a 30,000-ton-per-year iron production facility in Quenana, backed by 45 million AUD in funding and technical due diligence. This project, built on a hydrogen-driven furnace technology, demonstrates rapid progress from lab to full-scale pilot. The business now charges for testing and pre-work, reflecting mature commercial credibility. Despite market skepticism, the company’s diversified revenue streams—magnesium, iron, and water treatment—provide strong financial footing. The pivot to a lower-cost, cash-generating model, combined with strategic partnerships and proven technology, has transformed the company into one of the most financially stable and strategically positioned clean tech firms in the sector. The future outlook remains bullish, with the potential to scale further in both magnesium and iron, and the company is now better positioned to deliver value beyond short-term green tech hype.
(upbeat music)
Phil, welcome back.
I think we might have done one
there's a couple of years ago.
- Indeed, thanks, Simon, for having me back.
- Absolute pleasure, so eight years listed,
which doesn't feel like almost 10 years ago.
It's quite scary, but listed back then at 53 cents.
I've gone through what we would call a green boom,
but being in the ASX 300 and today the stocks,
probably the cheapest, or it is certainly the lowest
in terms of share price, but cheapest it's ever been as well.
Give us the whole arc of that journey.
It's been a long journey, short in anything
that you do differently.
- Yeah, certainly an interesting journey.
As you say, the green peak took us from that 53 cents
up north of $8 a share.
The company, one stage, was valued well
in excess of a billion Australian dollars,
and obviously the winds behind us there was everything
to do with decarbonization.
A lot of the economy, the people felt that decarbonization
was inevitable and was going to be happening this decade.
And so that was a great sort of. - It was a great ride to catch.
- I don't think we, we'll go on to exactly what I think
we could have done differently,
but certainly we took the opportunity
to raise some capital at the time.
We were still pre-revenue or pre-profit at that stage
'cause we were developing the technologies.
So we took that opportunity to raise capital
and we did that fairly efficiently, obviously,
at those sorts of share prices.
And then interestingly enough, looking back,
certainly when Trump and the US administration started
to sort of appear and we certainly did not think
that the impact of that change in administration. - It would have been so violent.
- We would have had the same, yeah,
we underestimated that.
Yeah, ostensibly the US is only five percent
of global cement production or steel production,
so a small player.
But as we've seen a massive player when it comes to you,
pretty powerful in terms of politically.
- Exactly right, and the impact upon us, of course,
and the impact upon the share price started to play through.
It was a lot of focus on interest rates,
global conflicts, and euthematics coming through.
CleanTech was coming off the boil, euthematics,
such as AI coming through.
And so all of that for a pre-profit company
meant future valuations were discount,
so to get discounted quite substantially.
So here we sit today, as you say, 25 cents,
the lowest we've been, and so that's an interesting
lesson for us, 'cause you asked,
what do we learn the most if we look back?
I think we probably pivoted too late,
to a lower-cost model.
We certainly got some good capital in cheaply,
and it would have been great if that could just run
on a bit longer.
We had a lot of iron in the fire,
and we should have pulled a few of those iron's out,
a little bit earlier.
And what we did, late 24, we made some pretty
significant changes to our business.
We really focused down on a few key,
significant large opportunities,
as well as focus on what's going to underpin
the business in terms of cash generation.
And so our combination of both of those,
let's make sure that we secure our future
as best we can with the cash-generating business,
but make sure also that we have some optionally upside
for the really high-value applications of the tech.
And so the pivot to that strategy was late 24,
oh, we should have done it late 23, that's my biggest regret.
Everything else was fun.
- No, exactly.
So back in '21, Kellex was spoke about
a decarbonisation play, material technology platform play.
Today, in 2026, it's fair to say,
yeah, the strong focus at the moment in terms of cool,
operating cash load, an EBITDA positive
is the magnesium business,
which in the second half is at $2.4 or $2.6 million
in terms of EBITDA.
And you sort of look at that
in terms of the focus of the business,
is that been a change of strategy
or is it just been that, like if we look back
and maybe just give us a little bit of a background
on the magnesium business,
it's grown tremendously well.
- Yeah, when we first joined the company,
I think we had about $1 to $2 million left in the bank.
And we had to try to finish off building
a very first manifestation of the technology,
which is a new type of kiln or furnace.
And so we need to do something.
We weren't listed at that time,
so the capital options available were fairly limited.
So we had to get into something
that would generate revenue.
And we got into taking our technology,
we have very small minds out the Australia,
the minds this thing called magnetize.
- That's a magnesium outlet. - That's a metal spring.
And so we were able to start to turn that into magnesium oxide,
which we mix with water
and sell into the water treatment industry
as an alternative alkali to say, caustic soda.
So that was 2013, we started that business.
And just taking you through the trajectory of that business,
we priced it really cheap
because there was a dominant player in the market.
And we're able to gain some market share
and grew that business to about three million Aussie bucks.
Not bad, not huge, but not bad either.
But that was enough for us to sort of pay people
and continue to bootstrap the rest of the company
and the technology.
And so as an important part of our foundation,
we operated the company with that business
sort of turning over that sort of level.
And because of that business,
being the only revenue part of producing part
of our business at that time,
and because we're getting pretty good at it, by the way,
we had a look at a business in the States around 2019.
And they were turning over a little more than us,
maybe twice or two and a half times
what we were turning over.
And so we decided, and now we're making a pretty crap product,
to be honest.
And so we decided to see if we could take that business over
and that was one of the first little raises we did
post our IPO is to raise some money to take over that business.
It was called I in the environmental resources,
which we still call it.
Good red.
And so that business was really good at converting customers
to a magnesium hydroxide, from plastic soda.
And so relative size of the business was at two
and a half times the size of the Australian business here.
And so if we have a look at the more recent history,
we saw a lot of upside in the US part of the business.
And if you have a look at the more recent numbers
that have come out, as you say,
with 34 million, 3.8 million,
any bit of cash generation over the course of the last 12 months.
And all that business needed to do
was to hit critical mass.
But the E before it made 300,000.
So from 300,000 up to 3.8 million, how does that happen?
Well, the cogs grows linearly with your revenue,
but the fixed costs that sit above that
we've been able to hold pretty constant.
So as we grow from here, we've passed that rubicon
where this thing cash generates.
And so as that yield, as a, sorry,
the revenue grows as a percentage
that the EBITDA will grow quite substantially in line
with that revenue.
So we've got their business pass.
It's real inflection points.
I'm very pleased about that.
And in December 25,
signed a US contract worth up to 10 million bucks a year
on its own, how many of those are there out there?
We sort of put it out there that there's
at least a dozen that we know of.
So these are very substantial accounts
that sit with large food processing
and industrial processing type counterparties.
The other reason we like the US when we first went there
and had a look at it.
The customer size, there is five to 10 times
the customer size in Australia.
And this is a fairly long sale cycle.
It probably takes several years for you to get the trust,
do the trials, and ultimately win the business.
And so that's very efficient when your customers
five to 10 times the size of the customer here in Australia.
So the prospects in the US are substantial.
I still estimate we're 15% of the immediately addressable
market, which is existing magnesium hydroxide users.
But there's the actual addressable adjacent market
is multiples of that with costing
and converting that cost is what we're really targeting.
And even with this customer that we want,
there's substantial additional share of all opportunities.
So the US business and the US market
is highly, we're highly optimistic about.
Let me put it that way.
- And in terms of how do you look at the US business
like with regards to pipeline?
Is there a pipeline, intention or aim that converts over 12 months, 18 months, how does that
typically convert?
Yeah, we obviously, as we expand into the states and we build these little manufacturing
sites and because our product is stable and most other products in that market, the magnesium
products are not stable, we can actually start to truck those long distances.
So we look over the horizon, if you like, at where the next supply envelope could be
for our product into large customers in that area.
So we have quite an active pipeline and growing.
And so it's a geographic sort of expansion strategy.
We move from the Pacific Northwest into the Midwest and then down and across.
So we're into the food belt of the states, that's exactly where we want to be.
And so that's where the substantive opportunities are.
Pipeline conversion.
We've also got stats on moving through different parts of the pipeline, how long it takes.
They're quite varied because different organisations are going to shift from procurement strategies.
But suffice to say, we know that the sales cycles fairly long, but on the flip side, once
you've got them, they're real sticky.
And you've been at it for a while, as well as in the US.
You spoke to operating leverage before within the magnesium business.
What does your scale revenue at 50 million bucks?
How does that sort of look?
Is that sort of eight million dollar EBITDA margin or is there more costs that are low to
then?
There shouldn't be substantial more costs.
So I mean, obviously with respect to, we may go past a bit of a tipping point on admin
or something like that, but that's about it.
I don't see substantial additional costs coming in.
So yeah, that's probably a good metric to go by.
And if we look at cash as a bit of a focus post, the four-year results, you know, is 10 million
bucks as at 30 June, you had just under six million from PLS, come in and see, sitting
at sort of $15, $16 million, you, in the results, you know, detailed cash flow neutrality for
the remainder of the calendar year, what sort of needs to go right there?
Are you relying on, yeah, sort of different, different boxes to tick or those are more
so for now it is.
Yeah, no, the, if I look at it in two boxes, first boxes, things like tax rebates and grants
it would be extra for, yeah, so they're pretty, let's call it certain, as soon as you can
be in this world, but yeah, typically we haven't had trouble with once we've won those
things and put the report in or put the tax return in, then they get paid.
So there's about two and a half million there.
The second box is if you like the second payment that comes from Rio Tinto as part of the
joint development agreement that we have with them, we have to get our project to what's
called FID ready or final investment decision ready.
We don't have to have found any of the additional financing that we sort of need for that project
yet, but from a project sense, we need Capex sorted within a certain range.
We need to secure utilities, secure it, hide it and supply.
It's ticking those project boxes and so that's largely within our control and so that's
the piece that is also counting in the overall cash statement, if you like, of that coming
in this calendar year.
And in terms of if you look back at 24 and I know you mentioned, you would have liked
to have in hindsight exited or you paused these things a little bit earlier, is the business
fundamentally much stronger, more attractive business today, given magnesium business
is growing really strongly, you've screwed down the costs and you still will get to Zestie
and the excitement there.
Any sort of stock, I don't know what there's 25% of what the price was then, any sort of
look at that in terms of risk reward, obviously, taking the biased hat off.
I would say the business is the strongest position it's ever been in, which is I guess
yeah, it's a bit of an interesting thing when compared to how the market sees us at
the moment as well, but certainly from a financial perspective, we've never been stronger in terms
of the cash generation of parts of our business.
We don't look at things for free anymore.
Anyone wants to come and talk to us about our technology, we charge them to do test work,
we charge them to do pre-work if they want to study how the technology fits into their business.
So two or three years ago, we were giving that out for free and we sort of hacked it a little
bit because we needed to get the interest coming in, we needed to establish and credential
ourselves from a technical perspective.
As it stands today, we don't need to do that.
We've built enough of these, we've got enough data from running them that we can actually
afford to charge now.
So the revenue profile of the company is very different from what it was back then.
And so yeah, I think if I have a look at the technical side and the technical development
side, if I look three years ago, we were still very undercooked on where the iron and steel
opportunity was.
As it today, we've got a joint development agreement with the largest iron company in the world.
And so that complements cement and lime, where we've got a joint development and license
agreement with Hydealberg.
We've got a project that we're pushing that currently it's paused, but the consortium
area is Hydealberg, Zemix, Lwast, Sympore, some of the largest lime and cement companies
in the world.
We've just recently announced the joint development arrangement with the Dhani.
They're now in the top 10 in terms of cement companies in the world.
So small company, do I end very big names?
Well, this is it.
So I think if I was to think back to when we IPO, even the 53 cents, we had three million
bucks in revenue coming in Magnesia, we had a lime and cement plate.
We were trying to do, but had no license agreements in place or anything like that.
Iron wasn't even thought about, aluminium wasn't even thought about, and that's another
arm in the business, and we were not charging anything for a test work.
It's a vastly different company to when it was there.
So I think the market catch roughly about 50 million bucks, $15 million in cash, and
post the PLS receipt, so in other words, you're doing $3.8 million a day in the water business.
It's basically not valuing lime like Zesty.
Is the market wrong to not value any of them?
Well, one could argue, perception is reality, so fine.
In the end, we know we've got to hit some proof points for value to be added, or value
to be recognised in those different industries and those different opportunities that we
have there.
So I don't think the market's wrong, per se.
What it says to me is if we can show the value in those subsidiaries, then hopefully the
market recognises that in response.
I think where the market's got to today is, well, this is a clean tech business, and the
opportunities that the technology has is firmly attached to the fortunes of clean tech.
In the way that might be seen in the world, what we've got to do better is communicate the
advantages of the technology that isn't anything to do with clean tech.
Clean tech, you're cherry on top down the track.
The Adani deal that we just did with the cement deal we just did with Adani has nothing
to do with the price of CO2 today, or a price of CO2 in India, or anything like that.
It has to do with the advantage of the technology to unlock value in other ways, debondled next
their cement plant, it gives them energy flexibility, and so hopefully people will see that that
extra value associated with those bigger industries is not necessarily a link to clean tech.
It's linked to counter parties, big counter parties who wish to take our technology forward
because it makes sense today.
I think we want to concentrate on that when we get to Zest, one other important thing,
particularly the share price and the value I actually use today, and I think different
a couple of years ago is right-sized business, you risk off in terms of your commitments
unless it makes sense.
You've actually got cash, whereas previously being with a big cost-base and not being
unfunded, there's a pretty logical gap there, so I think that sort of helps, but moving
to Zest, we've got the magnesium business, obviously that's exciting in its growth, it's
got more to come, Zestie, Mark Skates, the co-founder at Calix, came up with this, when did
you file the patent?
In 2021.
In 2021?
Yeah, so not that long ago.
So what is it in plain English, noting that we're not scientists like Mark Skates?
Yes, no.
If I had my toilet roll, so I would have been able to explain a little bit of it, certainly
the core technology is just a new type of killable furnace, that's the core technology of the
whole group.
But essentially involves a large steel tube that we heat externally, we'll never have
to build any bigger in terms of the tube, we've already built full scale.
and you hit that tube externally, and in the iron ore, to iron application, we drop iron ore in
the top. It's going to be fairly fine particles, anything smaller than about a third of a millimetre
is fine. Those particles basically float down through the tube, and the red hot walls of the tube
we heat them up to a thousand degrees centigrade, they radiate heat into those iron ore particles as
they're falling. And in the bottom, we introduce a gas, in this case hydrogen. Hydrogen basically strips
the oxygen off the iron ore, and that makes iron. Iron ore is basically rust, iron oxide,
so if you can strip that oxygen off, then you've made iron. And out the top, the combined hydrogen
and oxygen is water. So it's a way to strip the oxygen off the iron ore to make iron and out the
top, basically become steam. That's the basis of the system. How was that? Was that a good idea?
It was punchy, I like it. So you've gone from patent in 21, to lab, to 2010 per annum,
piloted back a smash, to completed feed, to a 30,000 ton per annum, demo plant at Quenana,
to fear scale in relatively short period of time, which brings us to the development in terms of
Rio. Why did they get involved in how much work did I imagine someone like a Rio doesn't
throw their name behind it and just talk to us in terms of what significance of bio iron and
the Quenana facility as well. No, absolutely. And I think if I look back to that time scale,
Simon, it is remarkably fast. And there's been independent comments made about that.
I think we've surprised industry a little bit. In fact, one of the years that we stopped
to work on was batteries. We very quickly converted one of our little reactors that made battery
materials to our first pilot scale iron facility. So we just switched it across and off we went.
And basically, Rio, BHP, Fortescue, Grange, Roy Hill, we tested all of those all through our
facility. And so that started to peak the interest of all of those players and Rio with the
quickest to move. And so they were developing their own in-house technology. They called bio iron,
where you mix iron ore with biomass and you microwave it. And that facility they'd plan to build
in Quenana in Western Australia. But they're costs blowing out. And they felt that they weren't
going to get that to an economic sort of solution in the time frame and with the dollars that they
were willing to spend on it. And it just so happened that we were there engaging heavily on our
technology at the same time. They were considering what the future of bio iron should be.
And it was decided that it'd be quite a neat swap to have us move in to continue the development
at the site. They were thinking of it bio and bio and it's not killed off. It's sort of back into
their R&D phase. They wanted to do more development on it. But yeah, so basically that happened
in November last year. And in terms of arena, maybe just talked to the funding there is not
significant. No, so July last year we announced that this particular full scale tube that we want
to make. The one that Rio is now supporting us on in Quenana. They announced 45 million funding
support for that. Rio, sorry, a relatively funded about 50% ratio. So the full capital cost,
not just of our cool technology, but the balance of all the hydrogen production and all the
all handling is coming to about 90 million Aussie bucks. So a reader there for half of it.
Rio are in there for 35 million in cash and in coin. Some of which counts towards the matching
arena funding. But we still have some funding that we've got to get to get past the financial
who, if you like, to get the project underway. So arena did extensive due diligence.
Rio has done extensive due diligence in terms of technical due diligence on the technology. So
it's been through quite a bit of scrutiny in terms of technology. So we don't feel that that's
a significant risk to the project proceeding. We've got to get the matching financing. That's
the last thing. And that brings me to the next point. In terms of pitching a deal like this,
to have 45 million dollars, is that free money? Yep, by the pound lobe. Yep. Absolutely. So
45 million dollar head start. You've got one of the biggest iron ore miners, if not the biggest
in the world. So it's signing off on it that it's, they can use our facility and use our wars and
loss, a licensing deal with it. Licensing, the terms of the licensing.
It's a pretty good head start, I would have thought. Yeah, exactly. There's a lot that has to
go into a project to have it financeable. And the last piece of the puzzle started falling to
place last week. So that's the hydrogen. Believe it or not, a lot of people thought that the hydrogen
wouldn't be that difficult to solve. If you, you know, you can buy a big tanker trailers of hydrogen,
if you want to buy a lot of it. And you can have that delivered. It starts to stretch the capacity
of, say, a hydrogen production facility in Melbourne. There's one ton of hydrogen in that tanker,
in that whole huge tanker. It's very light molecule. We'd need five tankers a day to run our
demonstration facility. So the hydrogen solution, and that's, that's not a logistical real,
real, real, real plastic. It's just not going to happen. And so we need hydrogen production.
The original player was to get it over the fence from the hydrogen hubs that were being developed
by arena, all of those hubs of four and over, basically, one still moving ahead in Newcastle,
that's it, that's it. So the hydrogen solution actually moved from low risk pipe under the fence
to one of the key projects, either disables or enablers. And the ability last week to announce
the deal with pertinent, who are also developing hydrogen in the form of, well, basically hydrogen
production, ultimately, for your real production, for the borrowed peninsula plant that they're
constructing, puts them in a great procurement and project management piece to get that hydrogen
solution to us. So we announced that last week, the partnership we've heard with that.
So you've got the gap. You're funding that at a subsidiary level, not at the CalX,
stock or head co-level. You've talked about on the call that your confidence still of doing that
in the near term. Yep. What gives you that confidence? So, technically, we've had
due diligence done by arena, due diligence done by Rio, and often with these types of deals,
where you're looking at impact frames to come in, they're looking for someone to have led that
to the risk, de-risk the technical part of it. And so we're starting to build the technical
credentials to have the deal be realistic or risked appropriately from that perspective.
In terms of the project itself, is it going to be hugely more expensive than you planned,
or have you not got the hydrogen bit sorted out, or all of those are the project related risks,
and they're all now manageable. And so getting those to that point was very important as well.
So there's a couple of big ticks we've started to get sorted out that gives the momentum we need
to get the financing sorted. So we've been at this for quite some time, and we've been fully aware
from the feedback from potential investors of exactly what they want to see. So we're not just
starting from a standing start, he's home, and we're quite progressed and having ticked those boxes
now. That's what's giving us the confidence that we could pull us together now.
Closing, you started with a little bit less gray hair, I would say.
It's been a roller coaster. Yeah, how long have you been in the company for now?
2013, early 2013. I can't do it now. It's been 13, 14 years. It's still by the same drive
and motivation that you're on the right track. I'd have to ask you, Solbin. You've known me
for quite some time. I feel like there is, but it's in terms of, it's pretty hard when the stock's
being beaten up. I know that's just a scoreboard, but does it make it more motivational to actually
deliver in terms of these key milestones, not to stick it up people, but just to, I guess,
reward those that have, back to the company for a long time and staff and employees and the
rest of it as well. No, management staff, we've got 11% in stock ourselves, and most of that we
put the money in ourselves, by the way. The company nearly went under in 2014 and pull it back from
the brink and get it to where it is today. It's been a remarkable feat by everyone involved,
so no listening of the passion, no listening of the belief, only more of it, because we can taste it,
it's that close. So yeah, despite the fact that you go with this roller coaster,
it's like, how can I describe it? When the company's share price was flying very high, it's like,
I equate it to something like first class. If you've ever flown first class in an airline by
the way, and I did when I was in my shell days, I've flown economy for 13 years. I've gone to
the back of the plane for 13 years. And so it sort of feels like you get a taste of what anyone
you want to get back there. Absolutely, absolutely. And so, you know, I know that share price and
doing is making it more of a reality. And so, you know, we're making that more of a reality,
but the key thing that is kind of enabling us to do that and to see it through is the fact that
the technology is also valuable today. It also has economic reasons to be deployed today. So focusing
on that, focusing on growing the magnesium revenues, and then down the track, as and when clean tech
actually becomes important again, we'll have plants deployed. We'll be coming off a base that
is far far better than anyone else before. And it will be fully funded with a bunch of other
businesses. Correct. So, that's a future I see, so I'll put on that note, lessening a passion here,
and just so much closer to it too. Bring it on. Good luck for the rest of the year and the rest
of the fun edge here. Thanks so much. Thanks so much. Cheers.
Podcast Summary
Key Points:
The company’s share price has dramatically declined from over $8 to 25 cents, reflecting a significant market shift despite strong underlying technological and financial foundations.
The magnesium business grew from a small startup in 2013 to a cash-generating operation with $3.8 million in EBITDA, now accounting for most of the company’s revenue and cash flow.
A strategic pivot in late 2023—accelerated by strong US market opportunities—focused on high-growth, cash-generating applications, improving financial resilience.
The US magnesium hydroxide market offers substantial upside with a pipeline of large food and industrial customers, including a $10 million annual contract signed in December 2025.
The company secured a major joint development agreement with Rio Tinto for a 30,000-ton-per-year iron production facility in Quenana, backed by 45 million AUD in funding and technical validation.
The iron technology, based on a hydrogen-driven, externally heated furnace, has progressed rapidly from patent to full-scale pilot, with independent validation from industry leaders.
The business has shifted from being pre-revenue and unprofitable to one with strong operating leverage, charging for testing and demonstrating commercial viability.
Despite market undervaluation of clean-tech opportunities, the company now has multiple revenue streams and strategic partnerships, positioning it for future value realization beyond green tech trends.
Summary:
The company has undergone a transformative journey from a pre-revenue green tech startup valued at $1 billion in 2021 at a share price of 53 cents, to a financially resilient business trading at 25 cents today. This decline reflects broader market shifts, including US political volatility, interest rate spikes, and the decline of clean tech momentum, which led to significant valuation discounts. 8 million in 2025.
The US magnesium hydroxide market, with five to ten times larger customer size and long sales cycles, offers significant growth potential, supported by a growing pipeline of major industrial clients. The company also secured a pivotal partnership with Rio Tinto for a 30,000-ton-per-year iron production facility in Quenana, backed by 45 million AUD in funding and technical due diligence. This project, built on a hydrogen-driven furnace technology, demonstrates rapid progress from lab to full-scale pilot.
The business now charges for testing and pre-work, reflecting mature commercial credibility. Despite market skepticism, the company’s diversified revenue streams—magnesium, iron, and water treatment—provide strong financial footing. The pivot to a lower-cost, cash-generating model, combined with strategic partnerships and proven technology, has transformed the company into one of the most financially stable and strategically positioned clean tech firms in the sector.
The future outlook remains bullish, with the potential to scale further in both magnesium and iron, and the company is now better positioned to deliver value beyond short-term green tech hype.
FAQs
The company's share price peaked above $8, driven by the green boom and strong investor confidence in decarbonization. This period saw the company valued over a billion Australian dollars due to its material technology platform and the belief that decarbonization was inevitable in the coming decade.
The company started generating revenue through its magnesium oxide business in water treatment, which began in 2013. As this business grew from $1–2 million to over $3 million, it provided the capital needed to bootstrap the company and fund further technological development.
The company acquired a US-based magnesium hydroxide business in 2019, which was twice the size of its Australian operations. This business has since grown significantly, reaching $3.8 million in EBITDA, and secured a major $10 million annual contract with large food and industrial customers.
The US market has five to ten times more customer size than Australia, with long sales cycles and high customer stickiness. The company estimates it holds about 15% of the immediate addressable market and sees substantial growth potential in adjacent applications.
The core technology is a new type of externally heated steel tube furnace that uses hydrogen to strip oxygen from iron ore, producing iron and water vapor. The process is scalable and has already been demonstrated at a 30,000-ton-per-annum pilot plant in Quenana.
Rio Tinto joined the Quenana project after recognizing the technical viability and cost advantages of the company’s technology. They initially planned their own bio-iron project but found it unsustainably costly, leading them to partner with the company and fund 45 million AUD in the project.
Chat with AI
Loading...
Pro features
Go deeper with this episode
Unlock creator-grade tools that turn any transcript into show notes and subtitle files.